Skip to main content

Pure-Play Psychedelic Stocks Index Continued To Decline Tuesday For 3rd Straight Day

The Pure-Play Psychedelic Stocks Index tracks the performance of 15 of the 31 biopharmaceutical companies involved in the research and development of psychedelic compounds to treat mental health issues and it was down 6.4% on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.